Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.89
+0.45 (5.33%)
At close: Jul 2, 2026, 4:00 PM EDT
8.91
+0.02 (0.22%)
After-hours: Jul 2, 2026, 7:50 PM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $540.47 million as of July 2, 2026. Its market cap has increased by 322.48% in one year.
Market Cap
540.47M
Enterprise Value
337.78M
1-Year Change
322.48%
Ranking
Category
Stock Price
$8.89
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $540.47M, a decrease of -39.82%. That is a compound annual growth rate of -19.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 540.47M | 0.64% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 567.88M |
| Contineum Therapeutics | 564.53M |
| Editas Medicine | 560.14M |
| Neurogene | 558.44M |
| Assembly Biosciences | 549.73M |
| Arvinas | 541.33M |
| Shattuck Labs | 540.60M |
| XOMA Royalty | 539.26M |